Immunotherapy is changing the way we perceive and treat cancer. Advances in science and technology have brought about a new wave of promising cancer immunotherapies, which harness the power of the immune system to fight disease. We are witnessing the emergence of a new vision within the cancer treatment landscape – one that is having an immediate and powerful impact on cancer patients everywhere.
Melinda Welsh who documented her diagnosis and treatment of squamous cell carcinoma of the head and neck in the Los Angeles Times. The first article discusses her diagnosis and the possibility of enrolling in a clinical trial to test OncoSec’s investigational therapy, ImmunoPulse® IL-12. The second article describes her treatment with ImmunoPulse® IL-12 and the results that she experienced. Her story is a poignant reminder of why OncoSec is focused on cancer immunotherapy and developing new treatments for patients. We continue to be inspired by stories like Melinda’s and hope to serve more patients in need.
To read Melinda’s testimonials, please visit: